Research ArticleCancer

Blockade of EGFR and MEK Intercepts Heterogeneous Mechanisms of Acquired Resistance to Anti-EGFR Therapies in Colorectal Cancer

Science Translational Medicine  19 Feb 2014:
Vol. 6, Issue 224, pp. 224ra26
DOI: 10.1126/scitranslmed.3007947

You are currently viewing the pdf extract.

View Full Text
As a service to the community, AAAS/Science has made this article free with registration.

You do not have access to the full text of this article, the first page of the PDF of this article appears below.

PDF extract preview